Management - Spark Newswire

4 minute read

Amarin Urges Shareholders To Vote “Against” Sarissa’s Harmful Proposals At Upcoming General Meeting Says ‘It Has No Plan, No New Ideas And An Underqualified Slate’

Today, 3:05 AM

The NEW Amarin and NEW Board is On the Right Track – Leading Independent Experts, ISS and Glass Lewis, Agree that Sarissa Representation is Not Warranted Sarissa's Misguided Campaign to Remove

AMRN

2 minute read

Cass Information Systems, Inc. Elects Martin Resch As President And Chief Executive Officer; Eric Brunngraber Named Executive Chairman

By Happy Mohamed

Today, 3:05 AM

Cass Information Systems, Inc. (NASDAQ:CASS), the leading provider of transportation, energy, telecom, and waste invoice payment and information services, announced that Martin Resch, President and Chief

CASS

2 minute read

East Palestine Community Update On Environmental Monitoring, Assistance For Feb. 16; Distributing Over $1.7M In Direct Financial Assistance To More Than 1,100 Families; Establishing A $1M Fund Available Immediately To The Community

By Happy Mohamed

Today, 3:05 AM

Norfolk Southern Corporation (NYSE:NSC) today provided an update on environmental monitoring and community assistance for the Village of East Palestine, Ohio. To date, Norfolk Southern has: Completed nearly 500

NSC

1 minute read

View To Seek Stockholder Approval Of Reverse Stock Split As Part Of Nasdaq Compliance Plan

By Happy Mohamed

Today, 3:05 AM

View, Inc. (NASDAQ:VIEW) ("View") today announced that it plans to hold a special meeting of stockholders to seek approval of a reverse stock split of View's Class A Common Stock, in order to regain

VIEW

2 minute read

Delix Inks Deal With Cellectricon; Psyched Wellness Partners With Spacestation

By Lara Goldstein

Today, 3:05 AM

Delix Nabs 2 New Partners Neuroscience company Delix Therapeutics is partnering with Sweden-based Cellectricon and New York-based Expressive Neuroscience. The goal is to expedite Delix's drug development pipeline.

PSYCF

2 minute read

Algernon Touts Positive Study Findings, Confirms Next Trial Phase With Escalated Dose

By Lara Goldstein

Today, 3:05 AM

Algernon Pharmaceuticals (OTCQB: AGNPF)’s subsidiary Algernon NeuroScience has completed the first cohort in its Phase 1 clinical study of

AGNPF

2 minute read

Novel Ketamine Topical Cream To Treat PTSD Gets First In-Human Trials

By Lara Goldstein

Today, 3:05 AM

Psycheceutical Bioscience (OTCPK: BWVI) is advancing its proprietary ketamine topical formulation into clinical studies. The life sciences company has partnered with Australian-based contract research organization iNGENū Pty Ltd.

BWVI

1 minute read

SNAP Says “In Q4, Total Time Spent Watching Spotlight More Than Doubled YoY; And Spotlight Submissions Went Up Nearly 20% Over The Same Time Frame”

By Happy Mohamed

Today, 3:05 AM

- Investor Day

SNAP

1 minute read

YouTube CEO Susan Wojcicki Steps Down, Says ‘Time Is Right For Me’

By Vandana Singh

Today, 3:05 AM

On Thursday, Alphabet Inc's (NASDAQ: GOOG) (NASDAQ: GOOGL) YouTube CEO Susan Wojcicki said that she's stepping down. Chief product officer Neal Mohan will lead as the SVP and new head of YouTube.

GOOG

1 minute read

Snap CEO Says Snapchat Now Has 750M Monthly Active Users

By Happy Mohamed

Today, 3:05 AM

- Investor Day

SNAP